{
    "Trade/Device Name(s)": [
        "Lumipulse G CA125II Immunoreaction Cartridges",
        "Lumipulse G CA125II Calibrators",
        "LUMIPULSE G1200 System"
    ],
    "Submitter Information": "Fujirebio Diagnostics, Inc.",
    "510(k) Number": "K142895",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020828"
    ],
    "Regulatory Class": "Class II and Class I",
    "Product Code(s)": [
        "LTK",
        "JIT",
        "JJE"
    ],
    "Summary Letter Date": "May 4, 2015",
    "Summary Letter Received Date": "May 5, 2015",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.6010",
        "21 CFR 862.1150",
        "21 CFR 862.2160"
    ],
    "Regulation Name(s)": [
        "Tumor-associated antigen immunological test system",
        "Calibrator",
        "Discrete photometric chemistry analyzer for clinical use"
    ],
    "Analyte Class(es)": [
        "cancer molecular",
        "chemistry",
        "immunology"
    ],
    "Analyte(s)": [
        "CA125"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "SST tube",
        "K2EDTA tube",
        "Lithium Heparin tube",
        "Sodium Heparin tube",
        "Red top serum tube"
    ],
    "Instrument(s)/Platform(s)": [
        "LUMIPULSE G1200 System",
        "LUMIPULSE G System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent Enzyme Immunoassay (CLEIA)"
    ],
    "Methodologies": [
        "Automated immunoassay",
        "Two-step sandwich immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Analyzer",
        "System",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Lumipulse G CA125II assay and calibrators using CLEIA technology on the LUMIPULSE G1200 system for quantitative CA125 measurement in serum and plasma.",
    "Indications for Use Summary": "Quantitative determination of CA125 in human serum and plasma using Lumipulse G CA125II as an aid in monitoring recurrence or progressive disease in ovarian cancer patients; calibrators for instrument calibration.",
    "fda_folder": "Immunology"
}